Saladax Biomedical, Inc. Appoints Mark D. Myslinski as Chief Commercial Officer
Saladax Biomedical, Inc., a privately held company developing and commercializing novel diagnostic assays to achieve the promise of personalized medicine for new and existing therapeutics, announced today that Mark D. Myslinski has been appointed senior vice president and chief commercial officer of the company.
Join the discussion below, or Read more at Freshnews.
#1 Jan 27, 2013
Add your comments below
|Gov't report: Efforts to reduce US uninsured st...||Jul 13||Repeal obama care||23|
|Insurance Co.'a are middle men||Jun 30||kneejerk52||1|
|Walgreens and LabCorp Collaborate to Bring Pati...||Jun 28||wagnous||1|
|Appalachian congressmen ask FDA to reclassify O... (May '07)||Jun 27||Ron Paul Liberty||37|
|Wanted Nashville suspect surrenders||Jun 24||baaarrrtt||2|
|This mother is looking for the lost necklace th...||Jun 22||Phyllis Schlafly ...||2|
|CDC panel again advises against FluMist||Jun 22||VACCINES MAIM KILL||1|
Find what you want!
Search Healthcare Industry Forum Now
Copyright © 2017 Topix LLC